Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Springer

Showing results (421-430 of 439) with videos related to

Pageof 44
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
BMC Public Health|November 5, 2021
Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohortR J Fredericksen, B M Whitney, E Trejo, et al.
Science (New York, N.Y.)|September 24, 2011
Impacts of the Cretaceous Terrestrial Revolution and KPg extinction on mammal diversificationRobert W Meredith, Jan E Janečka, John Gatesy, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segmentMin Shu, Jennifer L Loebach, Kerry A Parker, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsDong-Ming Shen, Min Shu, Christopher A Willoughby, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Physiological Genomics|November 22, 2012
11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculatureMingjuan J Luo, Rolf Thieringer, Martin S Springer, et al.
The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Pageof 44

Showing results (421-430 of 439) with videos related to

Sort By:
Pageof 44
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
1,3,4 Trisubstituted pyrrolidine CCR5 receptor antagonists bearing 4-aminoheterocycle substituted piperidine side chainsChristopher A Willoughby, Keith G Rosauer, Jeffery J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 4: synthesis of N-1 acidic functionality affording analogues with enhanced antiviral activity against HIVChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonistsK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
BMC Public Health|November 5, 2021
Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohortR J Fredericksen, B M Whitney, E Trejo, et al.
Science (New York, N.Y.)|September 24, 2011
Impacts of the Cretaceous Terrestrial Revolution and KPg extinction on mammal diversificationRobert W Meredith, Jan E Janečka, John Gatesy, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segmentMin Shu, Jennifer L Loebach, Kerry A Parker, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compoundsDong-Ming Shen, Min Shu, Christopher A Willoughby, et al.
Organic Letters|July 5, 2003
CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activityChristopher L Lynch, Jeffrey J Hale, Richard J Budhu, et al.
Physiological Genomics|November 22, 2012
11β-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculatureMingjuan J Luo, Rolf Thieringer, Martin S Springer, et al.
The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Pageof 44